Therapeutic potential of icatibant (HOE-140, JE-049)
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656566.9.13.2383
Reference55 articles.
1. New, long-acting, potent bradykinin antagonists
2. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies
3. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies
4. International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
5. The Kallikrein-Kinin System: Current and Future Pharmacological Targets
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In-Depth Serum Proteomics Reveals the Trajectory of Hallmarks of Cancer in Hepatitis B Virus–Related Liver Diseases;Molecular & Cellular Proteomics;2023-07
2. Bradykinin release following trauma and hemorrhagic shock causes pulmonary alveolar leak in a rodent model;Journal of Trauma and Acute Care Surgery;2023-06-14
3. The Role of Bradykinin Receptors in the Etiopathogenesis of Chronic Spontaneous Urticaria;Medicina;2021-10-19
4. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action;Biochemical Pharmacology;2021-01
5. Kinin-B2 Receptor Activity in Skeletal Muscle Regeneration and Myoblast Differentiation;Stem Cell Reviews and Reports;2018-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3